Literature DB >> 2342083

Opsonic requirements and surface hydrophobicity of novobiocin-resistant, coagulase-negative staphylococci.

L Maródi1, P Burján, F Rozgonyi.   

Abstract

The opsonic requirement for phagocytosis and killing and cell-surface hydrophobicity of five strains of Staphylococcus saprophyticus isolated from clinical sources were studied. Phagocytosis and killing of bacteria by human granulocytes were measured in suspension. Bacterial aggregating cell-surface hydrophobicity was determined by salt aggregation, and the absorptive hydrophobicity was measured by hydrophobic interaction chromatography. All strains were well opsonised by pooled normal human serum 10%. Ingestion of these bacteria could be detected to a variable extent in the absence of extracellular opsonins; heat-inactivated serum 10% or intravenous IgG concentrate 1 mg/ml improved phagocytosis of all strains. Significantly increased rates of both the ingestion and killing of one of the five strains occurred in the presence of IgG or in the absence of opsonins, compared to those found with each of the other four. This particular strain had significantly stronger adsorptive surface hydrophobicity than the other four strains, and with all strains there was a correlation between hydrophobicity and phagocytosis by granulocytes in the absence of opsonins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2342083     DOI: 10.1099/00222615-32-1-19

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  2 in total

1.  Anti-Pseudomonas aeruginosa IgY Antibodies Induce Specific Bacterial Aggregation and Internalization in Human Polymorphonuclear Neutrophils.

Authors:  K Thomsen; L Christophersen; T Bjarnsholt; P Ø Jensen; C Moser; N Høiby
Journal:  Infect Immun       Date:  2015-04-20       Impact factor: 3.441

2.  Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model.

Authors:  Mohammad Hadi Fakoor; Seyed Latif Mousavi Gargari; Parviz Owlia; Azar Sabokbar
Journal:  Infect Drug Resist       Date:  2020-06-09       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.